Attenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer. [electronic resource]
Producer: 20130129Description: 2598-607 p. digitalISSN:- 1090-0535
- Actins -- biosynthesis
- Apoptosis -- drug effects
- Cell Survival -- drug effects
- Cells, Cultured
- Cornea -- drug effects
- Fibrosis -- chemically induced
- Humans
- Immunoglobulin Fc Fragments -- chemistry
- Lipids -- chemistry
- Myofibroblasts -- drug effects
- Nanoparticles -- chemistry
- Plasmids -- chemistry
- Polyethyleneimine -- chemistry
- Protein Serine-Threonine Kinases -- chemistry
- Receptor, Transforming Growth Factor-beta Type II
- Receptors, Transforming Growth Factor beta -- chemistry
- Solubility
- Transfection -- methods
- Transforming Growth Factor beta1 -- adverse effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.